Board of Directors

Staffan Ternström
Chairman, COO Diagnostic Services, Medicover

Staffan has a solid background as an accomplished commercial oriented leader in medical devices. He has worked as EVP Global Commercial and Strategy for Mölnlycke Healthcare and spent nearly 25 years in various positions within Johnson & Johnson including senior positions based in Belgium as well as in Sweden. He is currently also a board member in Ferrosan Medical Devices.

Kay Brickmann
Board member, Business development director, AstraZeneca

Kay is in his global role at AstraZeneca responsible for partnering and in- and out-licensing of cardiovascular, renal and metabolism assets in early clinical and pre-clinical development. He has almost 20 years of post-doctoral experience of R&D, global alliance management and business development roles at AstraZeneca. He is the author/co-author of 15 research papers and 13 patents.

Klementina Österberg
Board Member, CEO of GU Ventures

Klementina leads the University of Gothenburg’s holding company GU Ventures, that operates as an incubator and invests in the commercialization of innovations. She works actively with financing, start-ups and managing companies within the GU Ventures AB sphere. Previous assignments include the business plan competition, Venture Cup, various Volvo companies, Daimler Chrysler and Geveko Industries.

Anders Tuv
Board member, Chief Investment Officer at Radforsk

Anders is investment director of the early-stage life science investment company Radforsk, which is focused on immunotherapies and precision medicines. He is an experienced investment and business development professional with broad experience from the life science industry covering management positions, strategy and business development, research collaborations, licensing deals, M&A and IPOs. He holds several chairman and non-executive director positions in Norwegian biotech companies. He holds an MBE degree.

Johan Öberg
Board member, Managing Director and Senior Partner, Global Sector Leader Tech Capital at Boston Consulting Group

Johan has a solid background consulting in the health care industry globally on strategic, M&A as well as operational topics. He leads BCG’s global Private Equity Practice, advising on investments and value creation in multiple industries but with a focus in health care. He is also a core member of the firm’s Health Care as well as Corporate Development and Global Advantage practices. Johan has been involved in OnDosis from the strategy definition and business plan development.

Adina Symreng
Board member, Partner at Boston Consulting Group

Adina has a background as MD (leg. läk.) and earned her PhD in clinical epidemiology at the Karolinska Institute. Adina has broad experience from the MedTech and Pharmaceutical industries, as well as Payer and Provider organizations. She previously worked as senior project leader with the Boston Consulting Group, leading life science projects in Europe, US and the Middle East. She currently serves as Strategy Director at Elekta.

Want to know more?

Get in touch